To elucidate the regulatory mechanism of AR by FKBP51 and FKBP52, we examined the expression of FKBP51 and FKBP52 in normal cells as well as multiple prostate cancer and bladder cancer cell lines (Fig. 1A). Here, AR is linked to urinary bladder carcinoma.